217 related articles for article (PubMed ID: 27419370)
21. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma.
Fogel M; Mechtersheimer S; Huszar M; Smirnov A; Abu-Dahi A; Tilgen W; Reichrath J; Georg T; Altevogt P; Gutwein P
Cancer Lett; 2003 Jan; 189(2):237-47. PubMed ID: 12490317
[TBL] [Abstract][Full Text] [Related]
22. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A
Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
[TBL] [Abstract][Full Text] [Related]
23. The L1 cell adhesion molecule is a potential biomarker of human distal nephron injury in acute tubular necrosis.
Allory Y; Audard V; Fontanges P; Ronco P; Debiec H
Kidney Int; 2008 Mar; 73(6):751-8. PubMed ID: 18059459
[TBL] [Abstract][Full Text] [Related]
24. L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
Kim HS; Yi SY; Jun HJ; Ahn JS; Ahn MJ; Lee J; Kim Y; Cui ZY; Hong HJ; Kim JM; Li S; Hwang IG; Park K
APMIS; 2009 Feb; 117(2):140-6. PubMed ID: 19239436
[TBL] [Abstract][Full Text] [Related]
25. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of insulin-growth factor 1 and insulin-growth factor 1 receptor expression in gastrointestinal stromal tumors.
Gu MJ; Bae YK; Choi JH
Hepatogastroenterology; 2013 Sep; 60(126):1383-6. PubMed ID: 24298573
[TBL] [Abstract][Full Text] [Related]
27. The adhesion molecule L1 (CD171) promotes melanoma progression.
Meier F; Busch S; Gast D; Göppert A; Altevogt P; Maczey E; Riedle S; Garbe C; Schittek B
Int J Cancer; 2006 Aug; 119(3):549-55. PubMed ID: 16506207
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma.
Wolterink S; Moldenhauer G; Fogel M; Kiefel H; Pfeifer M; Lüttgau S; Gouveia R; Costa J; Endell J; Moebius U; Altevogt P
Cancer Res; 2010 Mar; 70(6):2504-15. PubMed ID: 20215505
[TBL] [Abstract][Full Text] [Related]
29. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
30. Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
Wachowiak R; Rawnaq T; Metzger R; Quaas A; Fiegel H; Kähler N; Rolle U; Izbicki JR; Kaifi J; Till H
Pediatr Surg Int; 2008 Dec; 24(12):1361-4. PubMed ID: 18972120
[TBL] [Abstract][Full Text] [Related]
31. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
Soovares P; Pasanen A; Bützow R; Lassus H
Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
[TBL] [Abstract][Full Text] [Related]
32. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
[TBL] [Abstract][Full Text] [Related]
33. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
[TBL] [Abstract][Full Text] [Related]
34. Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.
Rawnaq T; Kleinhans H; Uto M; Schurr PG; Reichelt U; Cataldegirmen G; Gawad KA; Yekebas EF; Schachner M; Izbicki JR; Kaifi JT
Anticancer Res; 2009 Apr; 29(4):1195-9. PubMed ID: 19414364
[TBL] [Abstract][Full Text] [Related]
35. Increased L1CAM (CD171) levels are associated with glioblastoma and metastatic brain tumors.
Wachowiak R; Krause M; Mayer S; Peukert N; Suttkus A; Müller WC; Lacher M; Meixensberger J; Nestler U
Medicine (Baltimore); 2018 Sep; 97(38):e12396. PubMed ID: 30235708
[TBL] [Abstract][Full Text] [Related]
36. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
[TBL] [Abstract][Full Text] [Related]
37. Distribution of neural cell adhesion molecule (NCAM/CD56) in gastrointestinal stromal tumours and their intra-abdominal mesenchymal mimics.
Agaimy A; Wünsch PH
J Clin Pathol; 2008 Apr; 61(4):499-503. PubMed ID: 17923471
[TBL] [Abstract][Full Text] [Related]
38. Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens.
Euer NI; Kaul S; Deissler H; Möbus VJ; Zeillinger R; Weidle UH
Oncol Rep; 2005 Mar; 13(3):375-87. PubMed ID: 15706405
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
40. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
